Bank Of Montreal Eagle Pharmaceuticals, Inc. Transaction History

Bank Of Montreal

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.34 - $5.6 $3,333 - $5,588	-998 Reduced 3.88%	24,696 $138,000
Q1 2024 May 13, 2024	BUY	$4.26 - $6.51 $109,456 - $167,267	25,694 New	25,694 $134,000
Q2 2023 Aug 02, 2023	BUY	$17.74 - $31.87 $856,930 - $1.54 Million	48,305 New	48,305 $939,000
Q4 2021 Feb 11, 2022	SELL	$45.82 - $56.9 $11 Million - $13.7 Million	-239,933 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$43.79 - $55.78 $4.15 Million - $5.29 Million	94,749 Added 65.26%	239,933 $13.2 Million
Q2 2021 Aug 12, 2021	BUY	$36.86 - $44.5 $5.35 Million - $6.46 Million	145,184 New	145,184 $6.42 Million

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.